MoneyWorks4Me

Lupin informs about press release

23 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding launch of the world’s first fixed-dose triple combination drug under the brand name Vilfuro-G® for the effective management of chronic obstructive pulmonary disease in India. 

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1803.50
Dr. Reddys Labs. 1212.95
Cipla 1343.80
Lupin 2014.35
Zydus Lifesciences 1134.85
View more..